Search alternatives:
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
n decrease » nn decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
n decrease » nn decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
nLTD decreases the molecular proximity between endogenous spine cofilin and F-actin
Published 2014“…(<b>A</b>) Two examples from control cultures illustrate that endogenous cofilin is present both in neurons (MAP2-positive) and astrocytes (GFAP-positive) <i>Yellow arrows</i> point to astrocytic GFAP-positive processes, which often express levels of endogenous cofilin greater than or equal to that in neurons. …”
-
9
-
10
Proteasome activity was decreased in the <i>myc-rpt6-S119A</i> mutant.
Published 2017“…The mean ± SEM rate of Suc-LLVY-AMC cleavage is decreased in the <i>myc-rpt6-S119A</i> mutant compared to the WT and <i>myc-rpt6-S119D</i> strains. …”
-
11
-
12
Viability of microencapsulated FP ICCs decreased with time post-transplantation.
Published 2013“…<p>A) Fluorescent images of encapsulated FP ICCs stained with 6-CFDA for viable cells (green) and PI for non-viable cells (red) to assess viability at (A) pre-transplantation, (B) day 1, (C) day 3, (D) day 7, (E) day 14 and (F) day 21 post-transplantation. B) Viability decreased with time post-transplantation. Values are mean ± SEM (n = 100 microcapsules/mice for each time point); *p<0.05 viability for days 7 to 21 when compared to pre-transplantation control and days 1 and 3 post-transplantation; #p<0.05 viability for days 14 and 21 when compared to day 7 post-transplantation (one-way ANOVA with post-hoc Tukey-Kramer Multiple-Comparison test).…”
-
13
-
14
-
15
-
16
-
17
-
18
IgG-mediated systemic anaphylaxis decreased in BasoDTR mice.
Published 2013“…<p>(A) BasoDTR mice (n = 4 per group) were treated once i.p. with 25 or 50 µg/kg of DT or PBS at 4 days prior to and were i.v. injected with 500 µg rat anti-FcγRII/III (2.4G2) antibodies in 200 µl PBS. …”
-
19
Loss of C9orf72 decreases mTOR activation.
Published 2016“…Knockdown of C9orf72 significantly decreased p-S6K1 levels compared with cells treated with control shRNA (n = 3, *<i>p</i><0.5). …”
-
20